2-fluorofucose
Alternative Names: 2-fluorofucose peracetate; 2FF; SGD-2083; SGN-2FFLatest Information Update: 12 Oct 2020
Price :
$50 *
At a glance
- Originator Seattle Genetics
- Developer Seagen
- Class Antineoplastics; Small molecules
- Mechanism of Action Carbohydrate metabolism inhibitors; T lymphocyte modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours; Vaso-occlusive crisis
Most Recent Events
- 08 Oct 2020 Seattle Genetics is now called Seagen
- 28 Mar 2020 No recent reports of development identified for phase-I development in Solid-tumours(Late-stage disease, Metastatic disease, Second-line therapy or greater) in USA (PO)
- 25 Nov 2019 Chemical structure information added